AcuCort AB Company Description

AcuCort AB (publ) develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

It offers Zeqmelit, a medicine used for the treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting, as well as for the treatment of COVID-19 patients who need supplemental oxygen treatment.

AcuCort AB (publ) was incorporated in 2006 and is based in Lund, Sweden.

AcuCort AB (publ)

Country	Sweden
Founded	2006
Industry	Pharmaceutical Preparations
Employees	4
CEO	Jonas Jonmark

Contact Details

Address: Medicon Village Lund, 223 81 Sweden
Website	acucort.com

Stock Details

Ticker Symbol	ACUC
Exchange	Nordic Growth Market
Fiscal Year	January - December
Reporting Currency	SEK
SIC Code	2834

Key Executives

Name	Position
Jonas Jonmark	Chief Executive Officer